2-bromo-1-(4-phenyldiazenylphenyl)ethanone | 62625-24-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 偶氮苯
• 英文名称: 2-bromo-1-(4-phenyldiazenylphenyl)ethanone
• 英文别名: 4-(Phenylazo)phenacyl bromide
• CAS: 62625-24-5
• 化学式: C₁₄H₁₁BrN₂O
• 分子量: 303.158
• InChiKey: ZXTGCMLCYPYCID-WUKNDPDISA-N

物化性质

• 熔点：
  104 °C
• 沸点：
  427.0±25.0 °C(Predicted)
• 密度：
  1.37±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.68
• 重原子数：
  18.0
• 可旋转键数：
  4.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  41.79
• 氢给体数：
  0.0
• 氢受体数：
  3.0

安全信息

• 危险等级：
  8
• 海关编码：
  2927000090

反应信息

• 作为反应物：
  描述：

  2-bromo-1-(4-phenyldiazenylphenyl)ethanone 在 溴 、 三乙胺 作用下， 以 氯仿 、 丙酮 为溶剂， 反应 0.5h， 生成 (2S,3S)-2-Amino-3-methyl-pentanoic acid 2-oxo-2-(4-phenylazo-phenyl)-ethyl ester; hydrobromide
  参考文献：
  名称：

  Esterification of Amino Acids as Their 2,2-Bis(ethoxy-carbonyl)vinyl Derivatives

  摘要：

  描述了一种使用二乙基（乙氧基甲烯基）马来酸酯保护氨基酸氨基的方法。所得到的衍生物可以很容易地与不同的烷基化试剂进行酯化。通过在氯仿中用溴消除N-保护基团，可以得到氨基酸酯的溴化氢盐。

  DOI：

  10.1055/s-1989-27312

文献信息

• Substituted azole derivatives as therapeutic agents
  申请人：——

  公开号：US20040192743A1

  公开（公告）日：2004-09-30

  This invention provides azoles which may be useful as inhibitors of protein tyrosine phosphatases (PTPases). The present invention provides compounds of Formula (I), methods of their preparation, pharmaceutical compositions comprising the compounds and their use in treating human or animal disorders. The compounds of the invention may be useful as inhibitors of protein tyrosine phosphatases and thus can be useful for the management, treatment, control and adjunct treatment of diseases mediated by PTPase activity. Such diseases include Type I diabetes, Type II diabetes.

  这项发明提供了一些可能作为蛋白酪氨酸磷酸酶（PTPases）抑制剂有用的唑类化合物。本发明提供了式（I）的化合物，它们的制备方法，包含这些化合物的制药组合物以及它们在治疗人类或动物疾病中的应用。本发明的化合物可能作为蛋白酪氨酸磷酸酶的抑制剂有用，因此可用于管理、治疗、控制和辅助治疗由PTPase活性介导的疾病，如1型糖尿病、2型糖尿病等。
• Substituted Azole Derivatives as Therapeutic Agents
  申请人：Mjalli Adnan M. M.

  公开号：US20110077399A1

  公开（公告）日：2011-03-31

  This invention provides azoles which may be useful as inhibitors of protein tyrosine phosphatases (PTPases). The present invention provides compounds of Formula (I), methods of their preparation, pharmaceutical compositions comprising the compounds and their use in treating human or animal disorders. The compounds of the invention may be useful as inhibitors of protein tyrosine phosphatases and thus can be useful for the management, treatment, control and adjunct treatment of diseases mediated by PTPase activity. Such diseases include Type I diabetes, Type II diabetes.

  本发明提供了一些可能用作蛋白酪氨酸磷酸酶（PTPases）抑制剂的唑类化合物。本发明提供了式（I）的化合物，它们的制备方法，包含这些化合物的药物组合物以及它们在治疗人类或动物疾病方面的用途。本发明的化合物可能有用作蛋白酪氨酸磷酸酶的抑制剂，因此可以用于管理、治疗、控制和辅助治疗由PTPase活性介导的疾病，例如1型糖尿病、2型糖尿病。
• INDICATOR FOR ASSESSING BODY ODOR, PROCESS FOR PRODUCING THE SAME, BODY ODOR ASSESSMENT METHOD, METHOD OF ASSESSING EFFICACIOUSNESS OF DEODORANT AND KIT FOR CONVENIENTLY ASSESING BODY ODOR
  申请人：Kao Corporation

  公开号：EP1553411A1

  公开（公告）日：2005-07-13

  An indicator material for assessing body odor of the present invention comprises at least one member selected from the group consisting of a substance (A) which is a β-hydroxycarboxylic acid compound represented by the formula (1), a substance (B) which is a derivative of the compound represented by the formula (1), a substance (C) which is an alcohol compound having a mercapto group at the 3-position represented by the formula (2),and a substance (D) which is a derivative of the compound represented by the formula (2). The present invention also provides a method of producing the compound represented by the formula (2) by incubating perspiration originated from a human in an environment with an oxygen concentration of 10 v/v% or less. The present invention also provides a kit for assessing body odor of a human, wherein the kit for assessing body odor of a human includes a coloration reagent which reacts with β-hydroxycarboxylic acid originated from perspiration of a human. wherein R1 is an alkyl having 1 to 4 carbons; R2 is a hydrogen atom or an alkyl having 1 to 4 carbons, and the total number of carbons in the formula (1) is 10 or less; wherein R3 is a hydrogen atom or methyl group; R4 is an alkyl group having 1 to 3 carbons; and R5 is a hydrogen atom or a methyl group, the total number of carbons is 8 or less.

  本发明的一种用于评估体味的指示剂材料包括至少一种选自以下组成的成员：一种物质（A），它是β-羟基羧酸化合物，由式（1）表示；一种物质（B），它是由式（1）表示的化合物的衍生物；一种物质（C），它是由式（2）表示的在3-位上具有巯基的醇化合物；以及一种物质（D），它是由式（2）表示的化合物的衍生物。本发明还提供了一种通过在氧气浓度为 10 v/v% 或更低的环境中培养人的汗液来生产式（2）所代表的化合物的方法。本发明还提供了一种用于评估人的体味的试剂盒，其中用于评估人的体味的试剂盒包括一种与源自人的汗液的β-羟基羧酸反应的着色试剂。 其中 R1 是具有 1 至 4 个碳原子的烷基；R2 是氢原子或具有 1 至 4 个碳原子的烷基，且式（1）中的碳原子总数为 10 或更少； 其中 R3 是氢原子或甲基；R4 是具有 1 至 3 个碳原子的烷基；R5 是氢原子或甲基，碳原子总数为 8 或更少。
• Indicator for assessing body odor, process for producing the same, body odor assessment method, method of assessing efficaciousness of deodorant and kit for conveniently assessing body odor
  申请人：Hasegawa Yoshihiro

  公开号：US20060160240A1

  公开（公告）日：2006-07-20

  An indicator material for assessing body odor of the present invention comprises at least one member selected from the group consisting of a substance (A) which is a β-hydroxycarboxylic acid compound represented by the formula (1), a substance (B) which is a derivative of the compound represented by the formula (1), a substance (C) which is an alcohol compound having a mercapto group at the 3-position represented by the formula (2),and a substance (D) which is a derivative of the compound represented by the formula (2). The present invention also provides a method of producing the compound represented by the formula (2) by incubating perspiration originated from a human in an environment with an oxygen concentration of 10 v/v % or less. The present invention also provides a kit for assessing body odor of a human, wherein the kit for assessing body odor of a human includes a coloration reagent which reacts with β-hydroxycarboxylic acid originated from perspiration of a human.

  本发明的一种用于评估体味的指示剂材料包括至少一种选自以下组成的成员：一种物质（A），它是β-羟基羧酸化合物，由式（1）表示；一种物质（B），它是由式（1）表示的化合物的衍生物；一种物质（C），它是由式（2）表示的在3-位上具有巯基的醇化合物；以及一种物质（D），它是由式（2）表示的化合物的衍生物。本发明还提供了一种通过在氧气浓度为 10 v/v % 或更低的环境中培养人的汗液来生产式（2）所代表的化合物的方法。本发明还提供了一种用于评估人的体味的试剂盒，其中用于评估人的体味的试剂盒包括一种着色试剂，该试剂与源自人的汗液的β-羟基羧酸反应。
• SUBSTITUTED AZOLE DERIVATIVES AS THERAPEUTIC AGENTS
  申请人：Transtech Pharma, Inc.

  公开号：EP1594847A2

  公开（公告）日：2005-11-16

表征谱图